Incyte (INCY) Share-based Compensation (2010 - 2026)

Incyte (INCY) posted Share-based Compensation of $7.0 million for Q1 2026, up 105.68% on a QoQ basis from -$122.4 million in Q3 2025, and down 88.59% year-over-year from $61.0 million in Q1 2025.

Incyte (INCY) Share-based Compensation (2010 - 2026) Analysis & Trends

Incyte's Share-based Compensation history runs 17 years deep, the most recent figure standing at $7.0 million for Q1 2026.

  • Quarterly Share-based Compensation fell 88.59% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$50.9 million (down 115.85% YoY) and the FY2025 annual result came in at $3.2 million, down 98.81% from the prior year.
  • Share-based Compensation was $7.0 million for Q1 2026 at Incyte, up from -$122.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $263.6 million in Q4 2024 and bottomed at -$122.4 million in Q3 2025.
  • A 5-year average of $36.0 million and a median of $23.3 million in 2023 frame the typical range for Share-based Compensation.
  • Peak annual rise in Share-based Compensation reached 2370.11% in 2023, while the deepest fall reached 203.45% in 2023.
  • Incyte's Share-based Compensation stood at $184.8 million in 2022, then tumbled by 87.4% to $23.3 million in 2023, then jumped by 1032.64% to $263.6 million in 2024, then tumbled by 146.44% to -$122.4 million in 2025, then soared by 105.68% to $7.0 million in 2026.
  • Business Quant data shows INCY's Share-based Compensation at $7.0 million in Q1 2026, -$122.4 million in Q3 2025, and $64.6 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Incyte 23.33 Bn 19.32 Bn 1.17 Bn 6.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.96 Mn
Mar 31, 2026 6.96 Mn
Sep 30, 2025 -122.43 Mn
Sep 30, 2025 -122.43 Mn
Jun 30, 2025 64.61 Mn
Jun 30, 2025 64.61 Mn
Mar 31, 2025 60.98 Mn
Mar 31, 2025 60.98 Mn
Dec 31, 2024 263.62 Mn
Dec 31, 2024 263.62 Mn
Sep 30, 2024 -113.98 Mn
Sep 30, 2024 -113.98 Mn
Jun 30, 2024 110.24 Mn
Jun 30, 2024 110.24 Mn
Mar 31, 2024 6.17 Mn
Mar 31, 2024 6.17 Mn
Dec 31, 2023 23.28 Mn
Dec 31, 2023 23.28 Mn
Jun 30, 2023 -48.10 Mn
Jun 30, 2023 -48.10 Mn